The urinary catheter is a long hollow flexible tube needed for emptying the bladder and collecting the urine in a drainage bag. The material of the tube may be rubber, silicone, or plastic. If the bladder is not emptied, the pressure is created in the kidney, which, under severe conditions, may lead to kidney failure.
The major driving forces are the rising prevalence of urinary incontinence, the growing geriatric population, the increasing rates of obesity, and the technological advancements in the material used for catheters.
The rising prevalence of urinary incontinence (UI) is expected to drive the market. For instance, according to the National Association for Incontinence, nearly 200 million people are affected by urinary incontinence (UI). As per the WomensHealth.gov, urinary incontinence is twice as common in women as in men, where stress urinary incontinence is most common among women who are pregnant, giving birth, or going through menopause. Thus, the rising prevalence of urinary incontinence is driving the market.
The increasing rates of obesity are also expected to drive the market over the forecast period. Some studies have shown that obesity is directly associated with urinary incontinence UI. According to several epidemiological studies by the National Institute of Health, each 5-unit increase in BMI can increase a person's risk of urinary incontinence by 60%. Obesity is an independent risk factor for stress-related urinary incontinence and is the most crucial risk factor for daily urinary incontinence (UI). In obesity people, fat deposits around the abdomen lead to a broad range of health problems, like hernia, nerve damage, and weakened bladder muscles, which could potentially result in urinary incontinence. For instance, according to WHO, in 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these, over 650 million were obese. Also, 39% of adults aged 18 years and over were overweight in 2016, and 13% were obese. Thus, the increasing obesity rates worldwide are expected to drive the market for urinary catheters in the coming years.
However, the risk of catheter-associated urinary tract infection (CAUTI), and alternative treatment options for urinary incontinence are likely to hinder the market growth.
The risk of catheter-associated urinary tract infection (CAUTI) is expected to hamper the market growth over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), urinary catheters are responsible for around 75 % of urinary tract infections that people acquire in the hospital. The risk of infection is more with an indwelling catheter. According to an article published in BMC Urology, indwelling urinary catheters are the leading cause of healthcare-associated urinary tract infections (UTIs). Some of the complications include allergic reaction, bladder stones, blood in the urine, injury to the urethra, kidney damage (with long-term indwelling catheters), septicemia, or infection of the urinary tract, kidneys, or blood.
The global urinary catheters market can be segmented by product type into indwelling (Foley) catheters, intermittent catheters, and external catheters.
The External catheters segment is expected to grow at a high rate over the forecast period, owing to the presence of increased number of research and development activities. For instance, according to an article published on June 14, 2019, a new type of female external catheter technology reduced inpatient catheter-associated UTIs, or CAUTIs, by 51.7%, according to data presented at the Annual Conference of the association for professionals in infection control and epidemiology. Additionally, the Foley utilization rate was reduced from 15.7% to 10.7%, and standardized infection ratio (SIR) decreased from 1.319 to 0.965, which is below the CDCs National Healthcare Safety Network goal of less than one.
The global urinary catheters market can be segmented by application into benign prostate hyperplasia (BPH), urinary incontinence, spinal cord injury, and other applications.
The urinary incontinence segment is expected to grow at a high rate over the forecast period, owing to the rising prevalence of urinary incontinence (UI). For instance, according to the National Association for Incontinence, urinary incontinence affects 200 million people globally. Also, 1 in 4 women of age 18 experience episodes of leaking urine involuntarily. Approximately, on average, women wait for 6.5 years from the first time they experience the symptoms until they get a diagnosis for their bladder control problems. Thus, the increasing prevalence of urinary incontinence is driving the market.
The benign prostate hyperplasia is expected to grow at a significant rate over the forecast period. It is a common condition in aging population especially men. For instance, according to the Urology Care Foundation, about half of the men of 51-60 years old have BPH and up to 90% of the men in the age of 80 years have BPH. Further, acute urinary retention is a serious complication related to BPH and often requires catheterization of the urinary bladder. Thus, the rising prevalence of BPH is driving the market.
The global urinary catheters market can be segmented by application into hospitals, ambulatory surgical centers, and others.
The hospital segment is expected to grow at a high rate over the forecast period, owing to the increasing use of catheters in the hospitals. For instance, in hospitals, hydrophilic and antimicrobial/antibacterial catheters are used to decrease the risk of CAUTIs (instead of using indwelling(Foley) catheters). This trend is especially seen in the US and developing regions like Latin America. Many key players are capitalizing on this trend and focusing on launching single-use catheters over indwelling catheters. Single-use catheters and self-catheterization not only lessen hospitalization time but also lower the risk of infections and reduce overall costs.
Geographically, the global urinary catheters market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America is dominating the global urinary catheters market in 2018 and is estimated to hold significant market size over the forecast period (2019-2026) owing to the rising adoption of urinary catheters, increasing incidence of urinary incontinence, better healthcare infrastructure, effective government policies, and high awareness among people regarding urinary dysfunction.
The rising adoption of urinary catheters is expected to drive the market over the forecast period. For instance, according to an article published in 2017 in the British Medical Journal Open, a study on the use of urinary catheters in England during 2012-2016 indicated that urinary catheters are highly ubiquitous with every one in five patients in the hospital and 1 in 14 in community care getting catheterized. Also, nearly 100 million catheters are sold each year, of which the US accounts for a significant share in buying the medical devices. Further, the American Academy of Family Physicians (AAFP) estimated that every year in the US, there are more than 250,000 surgeries carried out for the benign prostate hyperplasia (BPH) with approximately 2 million office visits. This may also rise on account of injury or trauma to the penis, urethra, or bladder and is also associated with the pregnancy. Also, UI affects around 6 million American men and 20 million American women at some point in their lives. Thus, the increasing use of urinary catheters is driving the market.
Competitive Landscape
The major players operating in the global urinary catheters market are B. Braun Melsungen, Coloplast, C.R. Bard, Hollister, Medtronic, Teleflex, Boston Scientific Corporation, Convatec Group Plc, and Urocare Products, Inc.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the urinary catheters market globally. For instance,
In February 2019, Safe Medical Design Inc. (SMD), a medical device company dedicated to developing safe and cost-effective solutions in urology, announced that the US FDA cleared the Signal Catheter for commercialization in the US.
In 2018, B. Braun invested 1 billion Euros in new productions as well as research and development projects to grow and secure market share.
In 2017, Coloplast acquired Lilial, a French direct-to-consumer home delivery company, is now able to deliver products directly to end-users in the company's five most important markets.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
